What is exosome therapy? Exosomes are tiny extracellular particles involved in cell-to-cell communication. They are being researched in many medical fields, and the term is increasingly used in aesthetic and hair-restoration marketing. Research interest, however, is not the same as proven routine treatment.
If you are considering an exosome-labelled service, begin with a consultation through Shape Zoom’s advanced technology treatments team and ask detailed questions about the exact product, evidence and local regulatory status.
Book an evidence-led consultation
What are exosomes?
Exosomes are membrane-bound particles released by cells. They can carry proteins, lipids and genetic material between cells, which is why researchers are studying their potential role in signalling, tissue biology and drug delivery.
Commercial products marketed as “exosomes” are not all equivalent. Source material, manufacturing, purification, storage and testing can differ. A product name alone does not establish safety, purity or effectiveness.
Why are they discussed in aesthetics?
Exosome products are promoted for skin quality, post-procedure support and hair or scalp concerns. Proposed benefits are usually based on signalling pathways or early studies. Patients should distinguish laboratory rationale from high-quality clinical evidence showing meaningful, repeatable results.
What does the regulatory picture mean?
Regulation varies by country and intended use. The US FDA states that there are currently no FDA-approved exosome products and has warned about unapproved products marketed with treatment claims. A Dubai clinic must follow UAE requirements, but international warnings are still a useful reminder to ask what exactly is being offered.
Do not accept vague descriptions such as “stem-cell technology” as sufficient information. Ask for the product manufacturer, ingredients, intended route of use, storage requirements and regulatory documentation relevant to the UAE.
Questions to ask before considering treatment
- What is the exact product name and manufacturer?
- What is its source and how is it processed?
- Is this use authorised by the relevant UAE regulator?
- What human clinical evidence supports this specific product and indication?
- How is sterility, storage and traceability maintained?
- What are the known and unknown risks?
- What established alternatives address my concern?
How does it differ from PRP or mesotherapy?
PRP is prepared from the patient’s own blood. Mesotherapy describes a delivery technique that may use different agents. Exosome-labelled products are manufactured biological preparations. They should not be treated as interchangeable, and evidence for one does not automatically support another.
For hair and scalp concerns, a clinician may instead discuss diagnosis-led options or mesotherapy with Dermapen where appropriate. The comparison should include evidence, risk, cost and expected benefit.
Red flags to avoid
- Claims to cure many unrelated conditions
- No identifiable manufacturer or batch information
- Guaranteed hair regrowth or permanent skin rejuvenation
- Pressure to buy a package before medical screening
- No discussion of uncertainty or adverse-event reporting
Frequently asked questions
Are exosomes stem cells?
No. Exosomes are particles released by cells; they are not living stem cells. Marketing may blur this distinction, so ask for precise terminology.
Is exosome therapy proven for hair loss?
Research is developing, but routine clinical claims should be treated cautiously. Hair loss should first be diagnosed so established options are not delayed.
Is topical use the same as injection?
No. Route of administration can change exposure and risk. Evidence for one method cannot automatically be applied to another.
How can I check if a product is legitimate?
Ask the clinic for product identity, manufacturer, UAE regulatory information, storage and traceability. Seek an independent medical opinion if the answers are unclear.
Bottom line: exosome science is promising as a research field, but patients should expect transparent product information, regulatory compliance and honest discussion of uncertainty before considering any treatment.
